Aziyo Biologics, Inc. AZYO
Set alert
1.49 0.00 0.00%
As of Sep 6, 3:59 PM ET
1.40 Day range 1.54
52-week range unavailable
- Open
- 1.45
- Prev close
- 1.49
- Mkt cap
- 24.21M
- Vol
- 8.10K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.40
- High
- 1.54
- Forward P/E
- -2.84
- Beta
- -0.17
- Short ratio
- 5.04
- Inst. own
- 78.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2023
- 50-d avg
- 2.31
- 200-d avg
- 4.11
- 1y target
- 12.50
Financial health
Altman Z-Score
-5.10 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 1.2×
FY 2018 5y median -1.8× FY 2025
P/S 5.0×
FY 2018 5y median 1.8× FY 2025
P/B 2.2×
FY 2018 5y median 2.2× FY 2025
P/FCF -1.4×
FY 2018 5y median -2.7× FY 2025
EV/EBITDA -1.2×
FY 2018 5y median -3.2× FY 2025
EV/Sales 2.6×
FY 2018 5y median 2.5× FY 2025
FCF Yield -72.6%
FY 2018 5y median -37.4% FY 2025
Profitability
Gross Margin 53.7%
FY 2018 5y median 43.9% FY 2025
Operating Margin -218.9%
FY 2018 5y median -54.0% FY 2025
Net Margin 434.2%
FY 2018 5y median -52.4% FY 2025
ROE 192.9%
FY 2018 5y median 116.6% FY 2025
ROIC -71.6%
FY 2018 5y median -71.6% FY 2025
ROA 85.6%
FY 2018 5y median -37.0% FY 2025
Growth (YoY)
Revenue -49.6%
FY 2018 FY 2025
Operating Income 24.5%
FY 2018 FY 2025
EPS (diluted) 169.4%
FY 2018 FY 2025
Free Cash Flow -97.8%
FY 2018 FY 2025
Financial Health
Current Ratio 2.2×
FY 2018 5y median 1.8× FY 2025
Quick Ratio 2.1×
FY 2018 5y median 1.5× FY 2025
Debt / Equity 0.2×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA 1.1×
FY 2018 5y median 0.5× FY 2025
Interest Coverage 69.5×
FY 2018 5y median -4.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31